Preventive Care Plan Design: ACA Requirements, Employer Funding, and ROI on Screenings

What the ACA Actually Mandates (and What It Doesn't)

The Affordable Care Act requires plans to cover 23 preventive health services at zero cost-sharing: screenings for cancer, cardiovascular disease, diabetes, depression, and infectious diseases, plus immunizations and counseling. That floor is non-negotiable. Most self-insured employers meet this requirement.

But the ACA floor is deliberately low. It covers broad-stroke preventive categories—not the more targeted screenings that identify disease earlier in specific populations. That gap is where employers can add value without legal exposure.

Self-insured plans can expand preventive benefits beyond ACA requirements. You own the claims data. You can see which screening gaps correlate with expensive downstream utilization. That insight drives plan design decisions that legal requirements don't.

Where Employers Are Adding Coverage (and Why)

Advanced imaging and genetic testing top the list. ACA covers routine mammography and colonoscopy. Few employers stop there.

• Coronary calcium scoring (CAC)—absent from ACA preventive list—costs $100–150 per member and reclassifies 30–40% of asymptomatic patients into higher risk tiers. Self-insured employers adding CAC to cardiovascular benefits see 12–18% reduction in subsequent cardiac events among screened populations.

• BRCA and hereditary cancer panels—not mandated—run $250–500 but identify high-risk women who then enter surveillance protocols costing far less than emergency cancer treatment. One regional employer offering hereditary cancer screening to women over 40 with family history caught two stage I cancers in 2,000 eligible members; treatment cost $180K total vs. projected stage III/IV cost of $850K+ per case.

• Continuous glucose monitors for prediabetics—ACA covers diabetes screening, not management tools for the prediabetic population. One Midwest self-insured group added CGM access for HbA1c 5.7–6.4. Three-year follow-up showed 34% of that cohort did not progress to diabetes, vs. 18% in the control year. Annual diabetes incidence dropped from 2.1% to 1.4% in that demographic.

Age-stratified and risk-stratified protocols matter more than blanket coverage. A 45-year-old with hypertension and obesity needs different preventive architecture than a 45-year-old with normal vitals and no family history.

Screenings That Actually Reduce Downstream Costs

Not all preventive expansions pay for themselves. Data from 50+ self-insured plans shows clear ROI separators:

High ROI (cost-positive within 2–3 years)

• Colorectal cancer screening in 50–75 age group: $0.47 return per $1 spent
• Hypertension screening and management in high-risk populations: $0.62 return per $1
• Depression screening + treatment initiation: $0.58 return per $1
• Cardiovascular risk stratification (CAC, lipid panels, blood pressure monitoring): $0.41 return per $1

Moderate ROI (break-even or marginal positive)

• Hepatitis C screening in baby boomers: $0.35 return per $1 (depends on treatment protocols)
• HPV vaccination for adults 27–45: $0.28 return per $1 (long tail on prevention, harder to measure in 2–3 year windows)
• Prostate cancer screening (PSA-driven protocols): highly variable, $0.15–$0.40, depends on age and informed decision-making

Negative ROI within plan horizon

• Comprehensive annual physicals for low-risk adults: $0.08 return per $1 (generates unnecessary downstream testing)
• Genetic screening for low-risk cancers without family history: $0.12 return per $1

The pattern: screenings that move people into active management (blood pressure medication, statin therapy, diabetes education) outperform screenings that identify disease but don't trigger sustained intervention.

Contract Levers: How to Fund Enhanced Benefits

Self-insured employers use three primary mechanisms to fund preventive expansions without raising overall premiums:

1. Carve out from medical trend. Instead of accepting 4.5% medical cost inflation across the board, set 2% trend and redirect 2.5% to preventive expansion. Requires discipline on claims management elsewhere.

2. Shift high-deductible plan (HDHP) design. Offer $500 preventive deductible (separate from medical deductible) with full prevention coverage above that threshold. Members using preventive benefits early gain data for better health management; plan saves 6–11% on claims within that cohort.

3. Vendor alignment. Contract with disease management or primary care platforms (DMP or VBC) at fixed per-member-per-month (PMPM) rates. $8–12 PMPM for cardiovascular risk management or diabetes prevention. Vendor assumes downside risk on avoidable admissions. Employer gets preventive expansion + cost floor.

Bottom Line

ACA preventive requirements set a floor, not a ceiling. Self-insured employers can legally add targeted screenings—coronary calcium scoring, hereditary cancer panels, CGM access for prediabetes—without ACA compliance risk.

Choose screenings with documented ROI: colorectal cancer screening, hypertension management, depression screening, and cardiovascular risk stratification deliver $0.40–$0.60 return per dollar within 2–3 years. Avoid low-ROI screenings that generate excess testing without driving sustained behavior change.

Fund expansions through trend reallocation, HDHP restructuring, or vendor capitation. Track outcomes quarterly. If a preventive benefit isn't reducing downstream utilization or shifting disease stage at diagnosis within 24 months, replace it.

Your claims data is your competitive advantage. Use it to design preventive care that your competitors—and employees at fully insured plans—don't have access to.